VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1426574
Sex: F
Age:
State: TX

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Moderate fever; chills; spasms at injection site; severe muscle pain; lymph node pain; sore throat; fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 17-MAR-2021 at 10:45 AM (at the age of 56-years-old), as a single dose for COVID-19 immunisation. The patient medical history included Type 2 diabetes, hypertension, high cholesterol, sleep apnoea, obesity. The patient past drug history was not reported. Concomitant medications included Amlodipine (MANUFACTURER UNKNOWN), Losartan (MANUFACTURER UNKNOWN) and Janumet (MANUFACTURER UNKNOWN) Lantus (MANUFACTURER UNKNOWN) Crestor (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 17Mar2021 6.00 PM the patient experienced moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain sore throat, and fatigue. The patient did not receive treatment for the reported events. The clinical outcome for Moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain, sore throat, and fatigue. was not recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Amlodopine; Janumet; LOSARTAN; LANTUS; CRESTOR

Current Illness:

ID: 1426575
Sex: F
Age:
State: KY

Vax Date: 03/04/2021
Onset Date: 03/06/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; This is a spontaneous report received from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in left arm on 04Mar2021 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid removal. The patient was allergic to shingles vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hormones (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) and vitamin (MANUFACTURER UNKNOWN) all for unknown indication from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID -19 vaccination. Since the vaccination, the patient was tested for COVID-19. On 06Mar2021, the patient experienced dizziness which started two days later had not resolved. On 17Mar2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The event dizziness is resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event dizziness. The clinical outcome of event dizziness was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: MELATONIN; MAGNESIUM; LEVOTHYROXINE

Current Illness:

ID: 1426576
Sex: F
Age:
State: MI

Vax Date: 03/02/2021
Onset Date: 03/11/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tooth infection; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6205), dose 1 via an unspecified route of administration, administered in arm right on 02Mar2021 at 18:45 (at the age of 62-years-old) as single for COVID-19 immunisation. Medical history included ongoing atrial fibrillation from 2012 (has had AFIB for 9 years now). There was no history of previous immunization with the Pfizer vaccine considered as suspect. The patient did not administer additional vaccines on same date of the Pfizer suspect and did not receive prior vaccinations within 4 weeks. The patient was not taking any concomitant medications. On 11Mar2021, the patient experienced tooth infection. On 13Mar2021, the patient started Amoxicilllin 500mg for 10 days with instructions to take 1 capsule every 8 hours. She was still taking the Amoxicillin as of 16Mar2021. She reported that she should finished with the Amoxicillin before she gets her second COVID-19 vaccine shot on 25Mar2021. She was scheduled for a root canal on 22Mar2021, and would be done with the Amoxicillin by that time. She asked if being on the Amoxicillin will effect her second COVID-19 vaccine dose. The patient did not visit emergency room or physician office due to the event. The outcome of the event was resolving. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: AFib (Verbatim: AFib)

ID: 1426577
Sex: M
Age:
State: TN

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Terrible tinnitus; This is a spontaneous report received from a contactable consumer, the patient. A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 30 years old) as a single dose for COVID-19 immunisation. Medical history included diabetes and high blood pressure. The patient did not have any allergies to food, medication or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19 and had not been tested positive for COVID-19, since the vaccination. Concomitant medications include NOVOLOG, OZEMPIC and insulin glargine. On 16Mar2021 at 04:30, the patient woke up with terrible tinnitus. The patient did not receive any treatment for tinnitus. The clinical outcome of tinnitus was resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: TOUJEO; NOVOLOG; OZEMPIC

Current Illness:

ID: 1426578
Sex: M
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness in left toes - mainly middle toes; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; unknown) via an unspecified route of administration into left arm as first single dose for COVID-19 immunisation on 18Mar2021 at 10:30 (at the age of 62 years). Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient had not been tested for COVID-19. The patient had allergies from dust mites and grass. Concomitant medications included nexum (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, floranase (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, florachrome (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, alegra (MANUFACTURER UNKNOWN) for unknown indication started from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 16:00, the patient experienced event numbness in left toes, mainly on middle toes. The clinical outcome of the event numbness in left toes was not recovered at the time of report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: ALEGRA; floranase; NEXUM; florachrome

Current Illness:

ID: 1426579
Sex: F
Age:
State: NC

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Vomiting; Chills; Fever; Headache; Muscle aches; This is a spontaneous report from a non-contactable other health care professional. A 58-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via unspecified route administered in left arm on 17Mar2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, low thyroid and breast cancer. The patient was allergic to penicillin and levaquin. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), letrozole (MANUFACTURER UNKNOWN), low-dose aspirin ((MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), via unspecified route administered in left arm on 23Feb2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, approximately 24 hours after receiving the vaccination, the patient experienced nausea, vomiting, chills, fever, headache and muscle aches. All events began to subside within 18 hours but still present. Therapeutic measures were taken as a result of nausea, vomiting, chills, fever, headache and muscle aches and included treatment with water, ibuprofen and rest. The clinical outcome of the events nausea, vomiting, chills, fever, headache and muscle aches were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: multivitamin; LETROZOLE; LEVOTHYROXINE; LISINOPRIL

Current Illness:

ID: 1426580
Sex: F
Age:
State: KS

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; muscle aches; chills; fatigue; rash on arms; This is a spontaneous report received from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in left arm on 17Mar2021 at 13:15 (at the age of 26-year-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient received birth control (MANUFACTURER UNKNOWN) within 2 weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in left arm on 24Feb2021 at 00:00 hours (at the age of 26-year-old), as a single dose for COVID-19 immunisation. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination patient had not been tested for COVID-19. The patient had codeine allergies. On 18Mar2021, the patient experienced fever, muscle aches, chills, fatigue and rash on arms. The patient did not receive any treatment for events. The clinical outcome of the events fever, muscle aches, chills, fatigue and rash on arms were recovering. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1426581
Sex: F
Age:
State: AL

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm is really sore. Hurts to lift; I had aches and pains in my upper backand shoulders; Joint pains in my wrist; I felt sick for 5 min and I had to lay down; I had aches and pains in my upper backand shoulders; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6205), via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 29-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19 prior to vaccination. The patient was allergic to zithromax (MANUFACTURE UNKNOWN) since an unspecified date. Concomitant medications were not reported. The patient was not tested for COVID-19 since having the vaccine. On 19Mar2021 at 07:15, the patient experienced really sore arm which had hurt to lift. She had aches and pains in her upper back and shoulders and also had joint pains with her wrist. The patient felt sick for 5 min and then had to lay down. No treatment was taken for the reported events. The clinical outcome of the events pain in arm, shoulder pain, wrist pain, feeling sick and upper back pain was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426582
Sex: M
Age:
State: MS

Vax Date: 03/04/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blood filled small blister; This is a spontaneous report from a contactable patient. A 66 years old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown), via an unspecified route of administration in left arm on 04Mar2021 at 00:00 as a single dose for COVID-19 immunisation (at the age of 66 years). Patients medical history included high blood pressure. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown), via an unspecified route of administration in left arm on 21Jan2021 at 00:00 as a single dose for COVID-19 immunisation and the events are not reported . The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested positive for COVID-19. The patient reported no allergies to medications, food, or other products. The patient experienced blood blister on 18Mar2021 at 00:00. The patient reported that area of blister has spread slightly. Therapeutic measures were not taken. The clinical outcome of blood blister was not resolved at the time of the report. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1426583
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: strep infection; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age, received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. Patient reported that she was scheduled to receive her second dose of Pfizer-BioNTech Covid19 vaccine today/tomorrow. She has recently been diagnosed with a strep infection, and was being treated with "amox/clav 875mg twice a day" and wanted to see if there was an interaction between the antibiotic and the vaccine. On an unknown date, she underwent a COVID test which came back as negative. She wanted to know what would happen if she was unable to receive her second dose, tomorrow?. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1426584
Sex: F
Age:
State: ME

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very fatigued; Foggy brained difficulty focusing; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; Foggy brained difficulty focusing; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration on left arm on 16Mar2021 at 12 hours (at the age of 48-year-old) as a single dose for COVID-19 immunisation. The medical history included known allergies of nutmeg, cayenne and lactose intolerant, autoimmune graves and hashimotos. The concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 17 hours, the patient felt very fatigued for approximately 36 hours after the vaccination and foggy brain, difficulty focusing, swelling, redness and itching at the shot location. Prior to vaccination, the patient was not diagnosed with COVID-19 and patient was not tested for COVID-19 since the vaccination. No treatment medications were taken for the reported events. The clinical outcome of the events was recovered on unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426585
Sex: F
Age:
State: NY

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme nausea; Mild headache; Arm soreness; This is a spontaneous report received from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) in the left arm via an unspecified route of administration on 18Mar2021 at 09:15 hours as a single dose (at the age of 32-years-old) for COVID-19 immunisation. The medical history included hypothyroidism and anemic and no known allergies. The concomitant medications included levothyroxin (MANUFACTURER UNKNOWN) and SETLAKIN for birth control. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 06:30 hours, the patient experienced extreme nausea, mild headache and arm soreness. Patient had not received any treatment for the events. The clinical outcome of the events nausea, headache and pain at extremity was not recovered at the time of this report. Information about lot number cannot be obtained. No further information is expected.

Other Meds: SETLAKIN; LEVOTHYROXIN

Current Illness:

ID: 1426586
Sex: M
Age:
State: NY

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Significant pain in the injected arm; muscle ache; general malaise; Fatigue; flu/cold like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 38-year old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported and the patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 23Feb2021 at 10:00 (at the age of 38-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 08:00, patient experienced significant pain in the injected arm, muscle aches, general malaise, fatigue, and flu/cold like symptoms. No drugs were taken for the treatment of significant pain in the injected arm, muscle aches, general malaise, fatigue, and flu/cold like symptoms. The clinical outcome of pain in arm, muscle aches, general malaise, fatigue, and flu like symptoms was recovering at time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426587
Sex: F
Age:
State: WA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; chills; sore neck; This is a spontaneous report received from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in her left arm on 18Mar2021 at 1200 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient medical history was none. Concomitant medications was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 25Feb2021 at 1200 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient had no allergies to medications, food, or other products. On 18Mar2021 at 2330 the patient experienced chills, fever, and a sore neck. It was reported that the patient had chills, a fever of 101(units unspecified) and a sore neck for 6 hours, beginning at 2330 and continuing until 0530 the next morning. The patient did not receive any treatment for the reported events. The clinical outcome for chills, fever and a sore neck were recovered on 19Mar2021 at 0530. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426588
Sex: F
Age:
State: PA

Vax Date: 03/13/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: excessive burping.; Experiencedmore serious GI discomfort 3 days; nausea; Body aches; Mild fever; Mild headache; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via unspecified route of administration in left arm on 13Mar2021 at 14:00 (at the age of 53-year-old) for COVID-19 immunisation. Medical history included GERD (Gastroesophageal reflux disease). Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. The patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since the vaccination. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 12:00, the patient experienced mild fever, mild headache, body aches, malaise and typical GERD (Gastroesophageal reflux disease) symptoms of nausea and excessive burping. Experienced more serious GI discomfort 3 days after vaccine but no need to hospitalized. Patient did not receive any treatment for adverse events. The clinical outcome of mild fever, mild headache, body aches, malaise, nausea and excessive burping was recovering. No further information is expected. Information about lot/batch number cannot be obtained.

Other Meds: CALCIUM; FISH OIL

Current Illness:

ID: 1426589
Sex: M
Age:
State: NY

Vax Date: 03/11/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hives on my stomach, side, arms, thighs; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old adult female patient received her unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 11:15 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patients medical history was not reported. The patient had allergies to various antibiotics, shellfish, bees, honey & other medicine additives. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 16Mar2021, the patient experienced hives 4-5 days later, on stomach, side, arms & thighs. The patient received benadryl & prednisone for the adverse events. The clinical outcome of the events hives on stomach, side, arms & thighs were not recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426590
Sex: F
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tooth and jaw started hurting; tooth and jaw started hurting; tired; flu like symptoms; achey; molar and gum around molar hurting; jaw is swollen, cannot bite down; molar and gum around molar hurting; jaw is swollen, cannot bite down; having difficulty opening her mouth; nauseous; This is a spontaneous report from a contactable consumer or other non hcp. A 73-year-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6207 and Expiration date: UNKNOWN), via an unspecified route of administration, in left arm on 17Mar2021 at 09:00(at the age of 73-years-old) as 2nd dose, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. The patient previously received first dose of BNT162B2 (Lot number: EN6201) and she had zero side effects with the first one.The patient experienced tooth and jaw started hurting, tired, flu like symptoms, achey, molar and gum around molar hurting, jaw is swollen, cannot bite down on 17Mar2021, and having difficulty opening her mouth, nauseous on unspecified date in Mar2021. The reporter stated that she received her second Pfizer Covid vaccine dose on 17Mar2021 at 9 AM on her left arm. At 4 pm the same day, she started experiencing pain in her right jaw. Her back molar area, jaw, and gum have been very painful to the touch and swollen. She stated she felt difficulty opening her mouth and was nauseous. She was concerned that the vaccine administrator did not aspirate prior to the IM injection and was concerned that it might have contributed to her side effects. She wanted more information on if this particular side effect has been reported. She stated she had zero side effects with the first one, stated she expected to have flu like symptoms after this second one, stated by previous night the flu symptoms had dissipated but jaw was worse and swollen, jaw was killing her, cannot open her mouth wide, stated the pain had stayed the same but it is just moving. Stated she saw a dentist and they confirmed this was not an issue with her tooth, but that the swelling of the jaw was pressing on the tooth. Stated she knows that the vaccine said it can cause joint pain and the mandible was technically a joint. She clarifies that her flu like symptoms included being tired and laying with a blanket and a little achy. Woke up that morning and she stated they were gone she hoped the jaw pain will go away, does not want it to go on into next week- have other people experienced this. She also stated that when she got the second dose of the vaccine, the guy gave it a little higher on her arm than the girl that administered the first vaccine and he did not pull back on the needle to look for blood, wondered if he could had given the vaccine into a blood vessel. Therapeutic measures were taken as a result of events that included Tylenol. The outcome of the events tooth and jaw started hurting, molar and gum around molar hurting and jaw is swollen, cannot bite down was reported as not resolved and the outcome of the events tired, flu like symptoms and achey was reported s resolved on 19Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426591
Sex: F
Age:
State: MA

Vax Date: 03/07/2021
Onset Date: 03/07/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received an unknown dose number of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration to the right arm on 07Mar2021 at 1245 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809,), via an unspecified route of administration to the arm on 14Feb2021, as a single dose for COVID-19 immunisation. Concomitant medications included crestor (MANUFACTURE UNKNOWN), mvi (MANUFACTURE UNKNOWN), calcium (MANUFACTURE UNKNOWN) and vit D3 (MANUFACTURE UNKNOWN). On 07Mar2021 at 1900, the patient experienced nausea and headache. The events resulted in a visit to the doctor/ other health care professional. No therapeutic measures were taken. Since the vaccination, the patient had not tested for COVID-19. The clinical outcomes of the events of nausea and headache were recovering at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: MVI; CALCIUM; VIT. D3; CRESTOR

Current Illness:

ID: 1426592
Sex: F
Age:
State: FL

Vax Date: 03/13/2021
Onset Date: 03/14/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stomach cramps; Headache; Arm hurt; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: OEN6208) via unspecified route of administration in left arm on 13Mar2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, rectal cancer, cervical cancer, allergies. The patient was allergic to sulfa, penicillin, ceclor, wheat, yeast, malt. Past drug history included ceclor had taken from an unspecified date. Concomitant medications included renew life probiotics (MANUFACTURER UNKNOWN), Buspirone (MANUFACTURER UNKNOWN), Montelucast (MANUFACTURER UNKNOWN), ZIO had taken within two weeks of vaccination for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 12:00, the patient experienced headache, arm hurt, stomach cramps, diarrhea, fatigue. No treatment was received for the events. The clinical outcome of headache, arm hurt, stomach cramps, diarrhea, fatigue was recovered on an unspecified date. No follow-up attempts are needed. No further information is expected.

Other Meds: BUSPIRONE; MONTELUCAST

Current Illness:

ID: 1426593
Sex: M
Age:
State: CA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EP6955) administered in the left arm on 18Mar2021 at 10:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included asthma, high blood pressure and hypothyroidism. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included enalapril (MANUFACTURE UNKNOWN), levothyroxine (MANUFACTURE UNKNOWN), albuterol (MANUFACTURE UNKNOWN). The patient was allergic to amoxicillin. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 18Mar2021 at 0100 hours, the patient experienced generalised muscle aches and headache. The patient reported muscle pain throughout entire body, including lower back, arms, and legs and very very mild headache which was noticeable only if paid attention. The patient did not receive any treatment for the events. The clinical outcome for generalised muscle aches and headache was not resolved. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ENALAPRIL; Albuterol; LEVOTHYROXINE

Current Illness:

ID: 1426594
Sex: F
Age:
State: OR

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Mild fever; Mild sore throat; Tiredness; Body rash; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 17:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included prozac (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. Patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient was not pregnant. The patient had not tested positive for COVID-19 since the vaccination. On 17Mar2021 at 17:00, the patient experienced headache, mild fever, mild sore throat, tiredness and body rash more than 24 hours after injections. Patient did not receive any treatment for the events. The clinical outcomes of the events headache, mild fever, mild sore throat, tiredness, body rash were recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: PROZAC

Current Illness:

ID: 1426595
Sex: M
Age:
State: DE

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Loose bowels to diarrheas; shoulder pain in joint, right arm; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL 9266) via an unspecified route of administration in his right arm on 19Feb2021 at 11:00 AM as single dose for COVID-19 immunisation. The patients medical history includes that of previous tonsillar cancer treated and clear. Patient was allergic to cipro and tomatoes. He previously received first dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient had received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID-19 prior to vaccination. He had not tested positive for COVID-19 since the vaccine. On 20Feb2021 at 09:00 AM, the patient experienced loose bowels to diarrhea, shoulder pain in joint, right arm, fatigue and brain fog. Patient did not receive any treatment for events. The clinical outcome of all events was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426596
Sex: F
Age:
State: NJ

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: stomach upset; Joint ache; Body aches; headache; weakness; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration, in left arm on 16Mar2021 at 12:30 (at the age of 72-years-old), as single dose for COVID-19 immunisation. Medical history included asthma and type 2 diabetes. The patient had allergic history to penicillin and also some adverse stomach reaction to antibiotics. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 23Feb2021. Concomitant medications included ADVAIR, metformin (MANUFACTURER UNKNOWN), CRESTOR, diltiazem (MANUFACTURER UNKNOWN), EFFEXOR, all for unknown indication from an unknown date. The patient had received other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient had experienced body aches, headache, weakness and dizziness. On 18Mar2021, the patient had experienced joint aches and stomach upset. No therapeutic measures were taken for the events reported. The clinical outcome of the events body aches, headache, weakness, dizziness, joint aches and stomach upset were recovering at the time of reporting. Information about lot number cannot be obtained. No further information is expected.

Other Meds: EFFEXOR; ADVAIR; METFORMIN; DILTIAZEM; CRESTOR

Current Illness:

ID: 1426597
Sex: F
Age:
State: NC

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever of 103 F/ temperature increased; Chills; Terrible head ache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6207) via an unspecified route of administration in the left arm as a single dose for COVID-19 Immunisation on 17Mar2021 at 09:00 (at the age of 70-year-old). Medical history and concomitant medications were not reported. The patient was not allergic to any medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021 at 11:30, the patient experienced fever of 103 F/ increased temperature, chills, terrible head ache and body ache. Around midnight temperature increased and by the morning she ran high fever of 103 F and also had chills, terrible head ache, body ache, for 2 days. The patient did not take any treatment for the reported events. The clinical outcome of the fever of 103 F/ increased temperature, chills, terrible head ache and body ache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426598
Sex: F
Age:
State: TN

Vax Date: 03/16/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient stated, yesterday afternoon she noticed a rash on both forearms. Red, itching, warm, red, not so much bumpy just red.; Feeling a little itchy on parts of body; Scalp itching; caller developed a red rash on her bilateral forearms & scalp started itching; Little fatigued; Thumb tingling and warm; Thumb tingling and warm; Patient stated, yesterday afternoon she noticed a rash on both forearms. Red, itching, warm, red, not so much bumpy just red.; Normally wakes up at 04:00 now wakes up at 07:00; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via an unspecified route of administration on 16Mar2021 as 1st dose, single for COVID-19 immunization. Medical history included had a mastectomy this past December also stated had 4 lymph nodes removed. Stated she had always been sensitive to chemicals but seems like she is more so now since mastectomy. Previously took epinephrine, steroids they increase her blood pressure really bad. Concomitant medications included omeprazole at 40 mg from 11Mar2021 and at 20 mg from 13Mar2021 to an unspecified stop date for acid reflux and H Pylori, famotidine (PEPCID AC) from 17Mar2021 to 18Mar2021. On 18Mar2021 (Thursday), afternoon she noticed a red rash on her bilateral forearms & scalp started itching, red, itching, warm, not so much bumpy just red, scalp itching, feeling a little itchy on parts of body, Thumb tingling and warm, Little fatigued. After about 30 minutes scalp was itching and then stopped and she looked at both forearms. After about 30 minutes subsided and she was still feeling itchy and took one teaspoon of Benadryl. Has not had anymore rash pop up, is feeling a little itchy on parts of the body. They cannot use Epinephrine at the dentist. Is scheduled to have second dose on 06Apr2021 and is really worried now. This past Saturday her doctor called in Omeprazole 40mg for acid reflux and HPylori. She took it on 11Mar2021 and was itching. She did not initially connect it with the Omeprazole, thought it was from salsa although she has eaten salsa before. Pharmacist recommended her to do a process of elimination. On 13Mar2021 she went and got over the counter Omeprazole 20mg and about an hour later broke out in a rash, big welts, stronger reaction than before. Then she was afraid coming up on the Tuesday because she was scheduled for her COVID 19 Vaccine. She went ahead to got the vaccine at the clinic. She added after the vaccination her left thumb felt a little tingly, it was fleeting it would go and come. She was also warm during her hour. She does not do anything with her right arm after her mastectomy. The sensation in thumb was very fleeting. After sitting for an hour she left and was a little fatigued, not like most people. Most people say there were knocked off their feet. Stated her son-in-law was knocked off his feet after his. Mentions also that he is an essential worker who had Covid back in July. Stated that her daughter said she felt like she had taken a lot of Benadryl after her vaccine, was just sleepy. Caller states that for herself and her sister it feels like it brought them down to normal people level. Stated they were way up there anyways. Caller mentioned she normally wakes up at 0400 and now wakes up at 0700 since the shot. Rash was primary concern. Doesn't know if it is from the Omeprazole. Stated pharmacist doesn't think it would still be from the Omeprazole at this time. Caller stated she doesn't know, doesn't know the half-life of Omeprazole. Mentioned that she took Pepcid after shot, on Wednesday and Thursday. States could there be something in the Pepcid that she's allergic too; something like that is in the Omeprazole. Mentioned has taken Pepcid tablets before. However, not by itself. She has taken it along with Benadryl. Said she had an appointment later today and needs to get some stuff done. Mentioned that she was wondering if she was more sensitive to chemicals now than before since they took out 4 lymph nodes with her mastectomy. Stated this effects her lymphatic system. Does not remember being this sensitive before. Still questioning if she should take her second vaccine. Mentions should she go and see and allergist. States they had told her previously they couldn't test for chemicals, but maybe now they could. Further information requested. The outcome of the event feeling a little itchy on parts of body was not recovered, outcome of the event scalp itching was recovered on an unspecified in Mar2021 and outcome of the other events was unknown. Information about Batch/lot number requested.

Other Meds: OMEPRAZOLE; PEPCID [FAMOTIDINE]

Current Illness:

ID: 1426599
Sex: F
Age:
State:

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bad headache; whole body muscle ache,; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration on 18Mar2021 (at the age of 45-year-old) for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, she was not diagnosed with COVID-19. Since the vaccination, she had not been tested positive for COVID-19. Concomitant medications were not reported. On 18Mar2021 at 22:00, she had experienced bad headache and whole body muscle ache which was getting worse overnight. The patient took Tylenol for the reported adverse events as a part of therapeutic measures. The clinical outcome of the events bad headache and whole body muscle ache was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426600
Sex: M
Age:
State: IL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left sided facial numbness; decreased movement of the facial muscles; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 15Mar2021 at 10:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and diabetes. The patient had no known drug allergies. Concomitant medications of included amlodipine (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), insulin (MANUFACTURER UNKNOWN), OZEMPIC and lisinopril (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not been tested positive for COVID-19. It was reported that within an hour or two patient experienced left sided facial numbness and decreased movement of the facial muscles and asymmetrical smile. It was reported that symptoms had improved slightly but still persists. On 15Mar2021, the patient experienced facial numbness and decreased movement of the facial muscles. The patient contacted doctor of medicine (MD), but instructed if symptoms worsened to seek emergency care. The patient did not receive any treatment for the reported events. The clinical outcome of the event facial numbness and decreased movement of the facial muscles was not recovered at the time of report; information about lot/ batch number cannot be obtained. No further information is expected.

Other Meds: AMLODIPINE; METOPROLOL; INSULIN; OZEMPIC; LISINOPRIL

Current Illness:

ID: 1426601
Sex: F
Age:
State: RI

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Inability to sleep night after second dose, itching of (pre-existent) eczema and several new hives on shoulder, breast, legs.; Itching of (pre-existent) eczema; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208), via an unspecified route of administration in the left arm on 18Mar2021 at 10:00 (at the age of 76-years-old), as a single dose for COVID-19 immunisation. Medical history included eczema, taste disorder, gastro-intestinal reflux, arthritis, drug allergy (sulfa drugs) and breast cancer (small lump). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 23Feb2021 at 10:00, as a single dose for COVID-19 immunisation. Concomitant medications included losartan (MANUFACTURER UNKOWN), pantoprazole (MANUFACTURER UNKOWN), rosuvastatin (MANUFACTURER UNKOWN) and sucralfate (MANUFACTURER UNKOWN) all for an unknown indication from an unspecified date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not tested positive for COVID-19 since the vaccination. On 18Mar2021 at 12:00, the patient experienced inability to sleep night after second dose, itching of (pre-existent) eczema and several new hives on shoulder, breast, legs. The patient self-administered EUCRISA and hydrocortisone was given as treatment for the events. The clinical outcomes of the events insomnia and itching were recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: SUCRALFATE; ROSUVASTATIN; LOSARTAN; PANTOPRAZOLE

Current Illness:

ID: 1426602
Sex: F
Age:
State: TX

Vax Date: 03/03/2021
Onset Date: 03/06/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed rash on abdomen arms and legs; Developed rash on abdomen arms and legs; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Eng202) via an unspecified route of administration in the left arm on 03Mar2021 at 16:15 hours (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The medical history included poison ivy reaction prior to vaccination and allergy to sulfa and statins. The concomitant medications included lisinopril/hydrochlorothiazide (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), SINGULAIR, BENADRYL and m (unspecified medication). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and was not tested for COVID-19 since having the vaccine. On 06Mar2021, the patient developed rash on abdomen, arms and legs. The events resulted in doctor or other healthcare professional office/clinic visit. The therapeutic measures taken as a result of the event included steroid shot. The clinical outcome of the event developed rash on abdomen, arms and legs was recovered on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR; METOPROLOL; LISINOPRIL/HYDROCHLOROTHIAZIDE; BENADRYL

Current Illness:

ID: 1426603
Sex: F
Age:
State: WI

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had stomach upset and felt horrible; had a soft stool, but not diarrhea; vomited several times; dry heaves.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non pregnant female patient received first dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 17Mar2021 at 10:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medication included diltiazem (MANUFACTURER UNKNOWN) capsule 240 mg and estradiol (MANUFACTURER UNKNOWN) tablet 2MG received within 2 weeks of vaccination. Allergies to medications, food, or other products reported to Sulfa. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient experienced stomach upset and felt horrible, had a soft stool, but not diarrhea and vomited several times and had the dry heaves on 18Mar2021 at 10:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the stomach upset, a soft stool, vomiting and dry heaves was resolving. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ESTRADIOL; DILTIAZEM

Current Illness:

ID: 1426604
Sex: F
Age:
State: IL

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Really congested; Feeling dizzy; This is a spontaneous report from a contactable consumer, the patient. A 70-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER1741) via an unspecified route of administration in the left arm on 18Mar2021 at 14:15 (at the age of 70-years-old) as a single dose, for COVID-19 immunisation. The patient's medical history included allergies (unspecified). The patient have allergies (unspecified) to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient's concomitant medication included vitamins (unspecified) (MANUFACTURER UNKNOWN) for an unknown indication since an unspecified date. On 18Mar2021 at 19:00 (a few hours after receiving the shot), the patient became really congested and started feeling dizzy. The patient did not receive any treatment for events. The clinical outcome of events really congested and feeling dizzy were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426605
Sex: F
Age:
State: IL

Vax Date: 03/15/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; neck stiffness and pain; extremely sore occipital bone; ; inabilityto move my neck from left to rightwithout pain; nauseated;; inner ear pain; eye sensitive to light; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: D46207) via an unspecified route of administration in the left arm on 15Mar2021 at 16:30 as a single dose for COVID-19 immunisation. The patient's medical history was not specified. Concomitant medications were Flonase, Levothyroxine, Lexapro, Xyzal, Nexium and Met started on unspecified dates. The patient had a history of allergies to food, medications or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient has received Flonase, Levothyroxine, Lexapro, Xyzal, Nexium and Met within 2 weeks of the vaccination. The patient had not tested positive for COVID-19 since having the vaccine. The patient had not diagnosed with COVID-19 prior to vaccination. On 16Mar2021, the patient experienced fatigue, neck stiffness and pain, extremely sore occipital bone, inability to move her neck from left to right without pain, nausea, inner ear pain and eyes that are sensitive to light. Events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fatigue, neck stiffness and pain, extremely sore occipital bone, inability to move my neck from left to right without pain, nausea, inner ear pain, eyes that are sensitive to light were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: 24.0; 24.0; Flonase; LEVOTHYROXINE; 24.0; 24.0

Current Illness:

ID: 1426606
Sex: F
Age:
State: PA

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shingles on chest back and right ear; feverish; body aches; fatigue; This is a spontaneous report from a contactable other healthcare professional. A 41-Year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201), via unspecified route of administration in left arm on 15Feb2021 at 04:45 pm (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not had symptoms associated with COVID-19. Patient had not tested positive for COVID-19 since having the vaccine. No known allergies to medications, food, or other products. On 16Feb2021, the day after vaccine, the patient experienced feverish, body aches and fatigue. On 04Mar2021, two weeks after the shot the patient ended up with shingles on chest back and in right ear. Treatment (unspecified) for shingles was ongoing and one ER visit for doctor. Therapeutic measures were taken for the event shingles. The clinical outcome of the events feverish, body aches, fatigue and shingles were not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1426607
Sex: F
Age:
State: OH

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Really bad cluster headache on righthand side of head; High blood pressure; Racing pulse rate; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 17Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), bromocriptine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and amitriptyline (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the left arm on 24Feb2021 at 15:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID -19 prior to vaccination and since the vaccination, the patient had not been tested for COVID -19. On 18Mar2021 at 02:00, the patient experienced really bad cluster headache on right hand side of head, fever, chills, high blood pressure and racing pulse rate. The patient did not receive any treatment for reported events. The clinical outcome of the events really bad cluster headache on right hand side of head, fever, chills, high blood pressure and racing pulse rate were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: BROMOCRIPTINE; AMITRIPTYLINE; PANTOPRAZOLE; SIMVASTATIN

Current Illness:

ID: 1426608
Sex: M
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy rash; Redness on my face; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received unknown single dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: Ep6955) via unspecified route of administration on the left arm on 17Mar2021 at 15:15, for COVID-19 immunisation. No medical history and the patient concomitant medications were not reported and he had no known allergies. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, at 12:30 the patient had itchy rash on the wrist about 30 hours after the vaccination, the rash spread overnight and itching felt worst and also the patient developed redness on the face. Treatment medications for the events included the use of BENADRYL. Also, it was reported that the redness on face improved after taking half a pill of Benadryl. The clinical outcome of itchy rash was not recovered and redness in the face was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426609
Sex: F
Age:
State: FL

Vax Date: 03/12/2021
Onset Date: 03/14/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes under left armpit; Painful lymph nodes under left armpit; This is a spontaneous report received from a contactable consumer, the patient. A 32-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6208) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 32-year-old), as single dose for COVID-19 immunisation. The patients medical history included fibromyalgia and penicillin allergy. The patients past drug history included penicillin (MANUFACTURER UNKNOWN) for unspecified indication. Concomitant medication included pantoprazole (MANUFACTURER UNKNOWN) for an unspecified indication and from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021, the patient had swollen and painful lymph nodes under left armpit. The clinical outcome of the events Painful lymph nodes under left armpit and swollen lymph nodes under left armpit was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 1426610
Sex: F
Age:
State: WI

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Inadvertant administration of > thanrecommended dose. Vial was notreconstituted with diluent and patientreceived 0.3ml of undiluted vaccine; Inadvertant administration of greater than recommended dose.; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an intramuscular route of administration on left arm on 19Mar2021 at 9:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. The patients allergies to medications, food, or other products were NKDA. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient was pregnant. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. It was unknown if the patient has tested for COVID-19 since the vaccination. Concomitant medication not reported. On 09Mar2021 at 9:30 the patient had inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and the patient received 0.3ml of undiluted vaccine. The clinical outcome for the event inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and patient received 0.3ml of undiluted vaccine was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1426611
Sex: F
Age:
State: PA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extremely fatigued; slight chills; slight nausea; This is a spontaneous report received from a contactable patient. A 75-years-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534 via an unspecified route of administration in left arm at 11:45 on 16Mar2021, at the age of 75 years as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included fish oil (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication, magnesium (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication, glucosamine (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication and biotin (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269 via an unspecified route of administration in left arm at 16:00 on 22Feb2021, as a single dose, for COVID-19 immunisation. After receiving second dose, patient experienced extremely fatigue, slight chills and slight nausea at 19:00 on 17Mar2021. The patient did not receive any treatment for events. Facility where the most recent COVID-19 vaccine was administered: Other. The clinical outcome of events extremely fatigued, slight chills and slight nausea was recovered on an unspecified date at the time of reporting. No follow up required. No further information expected.

Other Meds: FISH OIL; GLUCOSAMINE; BIOTIN; MAGNESIUM

Current Illness:

ID: 1426612
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Injection site pain; Fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 37-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN] via an unspecified route of administration in left arm on 08Mar2021, at 14:30(at the age of 37-year-old) as a single dose, for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), SYNTHROID and WELLBUTRIN. The patient experienced dizziness, vaccination site pain and fatigue on 08Mar2021, at 16:00. No therapeutic measures were taken for the reported events. The clinical outcome of events vaccination site pain, fatigue and dizziness was recovered on unknown date in Mar2021. Information about lot number cannot be obtained. No further information expected.

Other Meds: WELLBUTRIN; SYNTHROID; BUSPIRONE

Current Illness:

ID: 1426613
Sex: M
Age:
State: TX

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Confusion; Severe stomach pain; Balance; Body aches; severe vomiting/ puking; Temperature 100.3; Diarrhea; Fatigue; Arm ache; Severe nausea; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6204) via an unspecified route of administration in the left arm on 16Mar2021 at 13:00 (at the age of 74-years-old), as a single dose for COVID-19 immunisation. The patient medical history included Diabetes, emphysema, HTN, COPD, and COVID-19 on an unspecified date in Nov2020. Concomitant medications were not reported. The patient did not have allergies to food, medication and other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was tested positive for COVID-19 in Nov2020. Since the vaccination, the patient has not been tested for COVID-19. On 16Mar2021, at 1700, the patient experienced events, severe nausea, vomiting, puking, temperature 100.3(Units unspecified), arm ache, body aches, fatigue, severe stomach pain and diarrhea, balance, and confusion, The patient did not receive any treatment as a result of adverse events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care'. The clinical outcome of the events nausea, vomiting, fatigue, loss of balance, confusion, pain in arm, generalized body pains, stomach pain, diarrhea, and increase body temperature was recovered with sequelae. No follow-up attempts are possible; No further information is expected

Other Meds:

Current Illness:

ID: 1426614
Sex: F
Age:
State: OH

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; chills; tiredness; swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6206), via an unspecified route of administration in her left arm on 18Mar2021 at 17:00 hours (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Obstructive Sleep Apnea (OSA), pre-diabetic, obesity, non-alcoholic fatty liver disease and gastroparesis. No concomitant medications were not reported within two weeks of vaccination. The patient had previously received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6202), via an unspecified route of administration in her left arm on 25Feb2021 at 17:00 hours, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and the patient has not tested positive for COVID-19 since receiving the vaccine. On 18Mar2021, the patient experienced sore arm, chills, tiredness, and swollen lymph node. No therapeutic measures were taken as a result of the events experienced. The clinical outcome of the events sore arm, chills, tiredness and swollen lymph node was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426615
Sex: M
Age:
State: IL

Vax Date: 03/14/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph node in underarm area; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old-male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown,) via an unspecified route of administration in left arm on 14Mar2021 at 12:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient had no allergy to medications, food, or other products. The patient had not received any vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination and since the vaccination the patient had not been diagnosed with COVID-19. On 15Mar2021 at 18:00, the patient experienced swollen lymph node in underarm area. The patient had not received any therapeutic measure or treatment taken for the resulted adverse event. The clinical outcome of swollen lymph node was resolving. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426616
Sex: F
Age:
State: FL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness at the injection site; Mild itchy tingling type sensation and a mild pins and needles sensation all over her body; Mild itchy tingling type sensation and a mild pins and needles sensation all over her body; This is a spontaneous report from a contactable other hcp. (patient). A 47-years-old female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in Deltoid Right on 15Mar2021 15:58 (at the age of 47-years-old) (Batch/Lot Number: EN6206) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included ear disorder from 03Feb2021 to an unknown date. Caller stated this is all COVID issue post COVID. Caller stated this ended within the last maybe week or so. Concomitant medication(s) included omeprazole (OMEPRAZOLE) taken for gastrooesophageal reflux disease, start and stop date were not reported. The patient previously took a medication which was a steroid called Methylprednisolone for her ear problems that she ended up discontinuing because she had an adverse effect to the medication, so she discontinued it on 15Feb2021. Prior Vaccinations (within 4 weeks) and AE(s) following prior vaccinations details was reported as none. Caller stated she received the vaccine on Monday 15Mar2021 at 15:58 HR and three hours later noticed a pen and needle itchy sensation all over the body and it is mild not severe. Caller stated it was noticeable of course more like annoyance right now. Caller stated the other symptom was soreness at the injection site (on 15Mar2021 20:00). For pen and needle itchy sensation all over the body the as time went on and the following day it was a moderate type soreness then started declining so it is improving. Caller stated she was still feeling a little soreness, but it was improving. Called stated she was not certain of the seriousness criteria of the pen and needle itchy sensation all over the body. Caller stated she knew it was not feeling tingly and the pen needle feelings she did not feel before but now she was felling that sensation and she was not sure if it was connected. AE(s) did not require a visit to emergency room or physician office. Caller stated she tried antihistamine Benadryl (25mg) lot numbers: 1761324, expiration Mar2022, did not really, maybe a minor difference, but sensation is still there so not resolving. The outcome of the events mild itchy tingling type sensation and a mild pins and needles sensation all over her body was not recovered and outcome for soreness at the injection site was recovering. Information on Lot/Batch number was available. Additional information has been requested.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1426617
Sex: F
Age:
State: AL

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 16Mar2021 at 13:30(at the age of 43-years-old), as a single dose for COVID-19 immunization. The patient medical history included diabetic and latex allergy. The patient past drug history included lisinopril (MANUFACTURER UNKNOWN). Concomitant medications included januvia, metoprolol (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient had diagnosed with COVID-19. Since the vaccination patient had not been tested for COVID-19. The patient was allergic to latex and lisinopril. On 16Mar2021 at 15:30, the patient was ill for 2 full days, fever, nausea, chills, body aches and headache. The patient did not receive treatment for the reported events. The clinical outcome for illness, fever, nausea, chills, body aches, headache was recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: GLIPIZIDE; Januvia; METOPROLOL; SERTRALINE

Current Illness:

ID: 1426618
Sex: F
Age:
State: CO

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild soreness at site of injection; This is a spontaneous report received from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 04Mar2021 at 10:30 (at the age of 43-year-old) as a single dose, for COVID-19 immunisation. Medical history included hypothyroid and anemia. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) with a dose of 112 microgram, orally once a day and multivitamin. No known allergies were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 04Mar2021 at 17:30, the patient experienced mild soreness at site of injection. The patient did not receive any treatment for the adverse event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event mild soreness at site of injection was recovered on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXIN

Current Illness:

ID: 1426619
Sex: F
Age:
State:

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; This is a spontaneous report from non-contactable other healthcare professional. A 70-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the left deltoid muscle on 16Mar2021 (at the age of 70-year-old), as single dose for COVID-19 immunisation. Medical history included previous reactions of anaphylaxis to an unspecified eye gtt as a teenager. Concomitant medications were not reported. On 16May2021, the patient experienced headache during her 30-minute waiting period after the injection. Therapeutic measures were taken as a result of headache and included treatment with Tylenol, observation and snacks. The follow up response to treatment was excellent and the patient was stable to go home and follow up with PCP. The clinical outcome of headache was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426620
Sex: M
Age:
State: TN

Vax Date: 03/03/2021
Onset Date: 03/11/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: eight days after my first vaccine, I had a routine blood test and the results of my platelet count was 111.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration in the left arm on 03Mar2021 at 10:45 (at the age of 69 years old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high blood pressure, seasonal allergies, obstructive sleep apnea, and kidney stones. Concomitant medications included prescribed medications and two over the counter medications which are unspecified. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that he had been reading about the possibility of low platelet counts due to the vaccine. On 23Jun2020 his platelet count was 130, on the low normal range. On 11Mar2021, eight days after his first vaccine, he had a routine blood test and the results of his platelet count was 111 (low platelet count). The patient doubted if it had any correlation. The patient did not receive treatment for the event. The clinical outcome of abnormal platelet count was unknown. Information about lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426621
Sex: M
Age:
State: TX

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 100.4 Degree temperature; Chills; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; batch number: ER8727) in the left arm on 18Mar2021 at 11:30 hours (at the age 60-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had allergies to pollen in the air. Concomitant medications included vitamin-c (MANUFACTURE UNKNOWN), multi-vitamin (MANUFACTURE UNKNOWN) and ther-biotic complete (MANUFACTURE UNKNOWN). The patient underwent lab tests which included nasal swab test on 05Oct2020 and had tested negative. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, (on an unknown date) the patient had taken a COVID-19 test. On 19Mar2021 at 01:30 hours, the patient experienced 100.4 degree temperature and chills. No treatment was received for the adverse events. The clinical outcome of the reported events was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Multi-Vitamin; Ther-Biotic Complete; Vitamin C

Current Illness:

ID: 1426622
Sex: M
Age:
State: MI

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My face and hands flushed red for about 45 minutes about 30 minutes after the injection.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via unspecified route of administration on 18Mar2021 (at the age of 59-years-old) at 1000 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient medical history included myasthenia Gravis, Barret's, benign prostate hyperplasia (BHP), asthma, degenerative disc disease. The patient was allergic to actifed, biaxin, IVP dye(contrast), morphine, cologne/perfume. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received unspecified other medications within 2 weeks of vaccination. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 1245, the patient experienced face and hands flushed red for about 45 minutes (also reported as about 30 minutes after the injection). No therapeutic measures were taken as a result of face and hands flushed red. The clinical outcome of the event face and hands flushed red was recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426623
Sex: F
Age:
State: TX

Vax Date: 03/15/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Full body rash breakout; Small spots with raising and clear liquid in some; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6304), via an unspecified route of administration in the left arm on 15Mar2021 13:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included NUVARING for unknown indication. The patient has no known allergies to food, medications or other products. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 20:00 the patient experienced full body rash breakout and small spots with raising and clear liquid in some. The patient did not receive any treatment for rash. The clinical outcome of the events rash and rash macular was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NUVARING

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm